GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
HUMAN:APOE
Contents
Annotations
Qualifier | GO ID | GO term name | Reference | ECO ID | ECO term name | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|---|---|
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034380 |
high-density lipoprotein particle assembly |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0042158 |
lipoprotein biosynthetic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0033344 |
cholesterol efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0043395 |
heparan sulfate proteoglycan binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
part_of |
GO:0031012 |
extracellular matrix |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034447 |
very-low-density lipoprotein particle clearance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010629 |
negative regulation of gene expression |
ECO:0000250 |
sequence similarity evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:0071830 |
triglyceride-rich lipoprotein particle clearance |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0043395 |
heparan sulfate proteoglycan binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031175 |
neuron projection development |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0005615 |
extracellular space |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
enables |
GO:0042802 |
identical protein binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0050709 |
negative regulation of protein secretion |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
has_regulation_target:(UniProtKB:P10636)|regulates_o_occurs_in(CL:0002321) |
Seeded From UniProt |
complete | ||
part_of |
GO:0034362 |
low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034363 |
intermediate-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
enables |
GO:0008201 |
heparin binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0050750 |
low-density lipoprotein particle receptor binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0050750 |
low-density lipoprotein particle receptor binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0061136 |
regulation of proteasomal protein catabolic process |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0045893 |
positive regulation of transcription, DNA-templated |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010596 |
negative regulation of endothelial cell migration |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0005102 |
signaling receptor binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
F |
happens_during:(GO:0006497) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0071831 |
intermediate-density lipoprotein particle clearance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034382 |
chylomicron remnant clearance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0032462 |
regulation of protein homooligomerization |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_regulation_target:(UniProtKB:P05067:PRO_0000000093)|has_regulation_target:(UniProtKB:P05067:PRO_0000000092) |
Seeded From UniProt |
complete | ||
enables |
GO:0044877 |
protein-containing complex binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
has_direct_input:(ComplexPortal:CPX-1134) |
Seeded From UniProt |
complete | ||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
has_direct_input:(UniProtKB:P05067:PRO_0000000092) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1905906 |
regulation of amyloid fibril formation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_regulation_target:(UniProtKB:P05067:PRO_0000000093) |
Seeded From UniProt |
complete | ||
enables |
GO:0046983 |
protein dimerization activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
UniProtKB:P05067:PRO_0000000092 |
F |
occurs_in:(UBERON:0001359) |
Seeded From UniProt |
complete | |
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034363 |
intermediate-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034362 |
low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0042982 |
amyloid precursor protein metabolic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1900272 |
negative regulation of long-term synaptic potentiation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(UBERON:0001885) |
Seeded From UniProt |
complete | ||
part_of |
GO:0005615 |
extracellular space |
ECO:0000250 |
sequence similarity evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:0051246 |
regulation of protein metabolic process |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:2000822 |
regulation of behavioral fear response |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
regulates_o_occurs_in:(UBERON:0001876) |
Seeded From UniProt |
complete | ||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0045807 |
positive regulation of endocytosis |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_regulation_target:(GO:0034361) |
Seeded From UniProt |
complete | ||
part_of |
GO:0005576 |
extracellular region |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(UBERON:0007318) |
Seeded From UniProt |
complete | ||
part_of |
GO:0005615 |
extracellular space |
ECO:0000250 |
sequence similarity evidence used in manual assertion |
C |
part_of:(UBERON:0000955) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
UniProtKB:P05067:PRO_0000000092 |
P |
|
Seeded From UniProt |
complete | |
involved_in |
GO:0070328 |
triglyceride homeostasis |
ECO:0000250 |
sequence similarity evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010877 |
lipid transport involved in lipid storage |
ECO:0000250 |
sequence similarity evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0061771 |
response to caloric restriction |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0061771 |
response to caloric restriction |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0090181 |
regulation of cholesterol metabolic process |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:0042632 |
cholesterol homeostasis |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:0007616 |
long-term memory |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0035641 |
locomotory exploration behavior |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
UniProtKB:P05067:PRO_0000000093 |
F |
occurs_in:(GO:0034362)|occurs_in:(GO:0034363)|occurs_in:(GO:0034361) |
Seeded From UniProt |
complete | |
enables |
GO:0050750 |
low-density lipoprotein particle receptor binding |
ECO:0000303 |
author statement without traceable support used in manual assertion |
F |
Seeded From UniProt |
complete | |||
part_of |
GO:1990777 |
lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
part_of:(UBERON:0001359) |
Seeded From UniProt |
complete | ||
part_of |
GO:0062023 |
collagen-containing extracellular matrix |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:0010977 |
negative regulation of neuron projection development |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
part_of:(GO:1905890) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010976 |
positive regulation of neuron projection development |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(UBERON:0001997) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010976 |
positive regulation of neuron projection development |
ECO:0000250 |
sequence similarity evidence used in manual assertion |
P |
occurs_in:(UBERON:0001997) |
Seeded From UniProt |
complete | ||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
has_input:(CHEBI:64646) |
Seeded From UniProt |
complete | ||
enables |
GO:0042803 |
protein homodimerization activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
part_of |
GO:0005576 |
extracellular region |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:1905890 |
regulation of cellular response to very-low-density lipoprotein particle stimulus |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010976 |
positive regulation of neuron projection development |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
part_of:(GO:1905890) |
Seeded From UniProt |
complete | ||
part_of |
GO:0005576 |
extracellular region |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
occurs_in:(GO:0005576) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0032269 |
negative regulation of cellular protein metabolic process |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
has_agent:(GO:0034361) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
UniProtKB:O00755 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:1905860 |
positive regulation of heparan sulfate proteoglycan binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_regulation_target:(GO:0034361) |
Seeded From UniProt |
complete | ||
enables |
GO:0042803 |
protein homodimerization activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
occurs_in:(GO:0034364)|occurs_in:(GO:0034362)|occurs_in:(GO:0034363)|occurs_in:(GO:0034361) |
Seeded From UniProt |
complete | ||
part_of |
GO:0034362 |
low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0045807 |
positive regulation of endocytosis |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_regulation_target:(GO:0034361) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1905855 |
positive regulation of heparan sulfate binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:1905855 |
positive regulation of heparan sulfate binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
|
Seeded From UniProt |
complete | ||
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034363 |
intermediate-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0005794 |
Golgi apparatus |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0005783 |
endoplasmic reticulum |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0044794 |
positive regulation by host of viral process |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
has_regulation_target:(UniProtKB:Q81449) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0019068 |
virion assembly |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0070062 |
extracellular exosome |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0062023 |
collagen-containing extracellular matrix |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(CL:0002322) |
Seeded From UniProt |
complete | ||
part_of |
GO:1903561 |
extracellular vesicle |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(UBERON:0001359) |
Seeded From UniProt |
complete | ||
part_of |
GO:0016020 |
membrane |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:1903002 |
positive regulation of lipid transport across blood-brain barrier |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_input:(CHEBI:28125) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1902995 |
positive regulation of phospholipid efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1902952 |
positive regulation of dendritic spine maintenance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1902430 |
negative regulation of amyloid-beta formation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000540) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1901630 |
negative regulation of presynaptic membrane organization |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0034205) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1901628 |
positive regulation of postsynaptic membrane organization |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0034205) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1901215 |
negative regulation of neuron death |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0034205) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1900221 |
regulation of amyloid-beta clearance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0097114 |
NMDA glutamate receptor clustering |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0060996) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0097113 |
AMPA glutamate receptor clustering |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0060996) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0060999 |
positive regulation of dendritic spine development |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0048666) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0055089 |
fatty acid homeostasis |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_input:(CHEBI:15843)|has_input:(CHEBI:26208)|has_input:(CHEBI:28125) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0046889 |
positive regulation of lipid biosynthetic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0017038 |
protein import |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0015909 |
long-chain fatty acid transport |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_input:(CHEBI:28125) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010875 |
positive regulation of cholesterol efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
part_of |
GO:0072562 |
blood microparticle |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0070062 |
extracellular exosome |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(UBERON:0001088) |
Seeded From UniProt |
complete | ||
part_of |
GO:0070062 |
extracellular exosome |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(CL:0000639) |
Seeded From UniProt |
complete | ||
part_of |
GO:0005634 |
nucleus |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(CL:0000019) |
Seeded From UniProt |
complete | ||
part_of |
GO:0005615 |
extracellular space |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(UBERON:0001914) |
Seeded From UniProt |
complete | ||
enables |
GO:0070326 |
very-low-density lipoprotein particle receptor binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0070326 |
very-low-density lipoprotein particle receptor binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0060228 |
phosphatidylcholine-sterol O-acyltransferase activator activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0051000 |
positive regulation of nitric-oxide synthase activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0050750 |
low-density lipoprotein particle receptor binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0050750 |
low-density lipoprotein particle receptor binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0050728 |
negative regulation of inflammatory response |
ECO:0000305 |
curator inference used in manual assertion |
GO:0051000 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0048156 |
tau protein binding |
ECO:0000353 |
physical interaction evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0046911 |
metal chelating activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0045541 |
negative regulation of cholesterol biosynthetic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0043691 |
reverse cholesterol transport |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0043537 |
negative regulation of blood vessel endothelial cell migration |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0043407 |
negative regulation of MAP kinase activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0043025 |
neuronal cell body |
ECO:0000303 |
author statement without traceable support used in manual assertion |
C |
Seeded From UniProt |
complete | |||
enables |
GO:0042803 |
protein homodimerization activity |
ECO:0000353 |
physical interaction evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0042802 |
identical protein binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0042632 |
cholesterol homeostasis |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0042627 |
chylomicron |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0042627 |
chylomicron |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034447 |
very-low-density lipoprotein particle clearance |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034447 |
very-low-density lipoprotein particle clearance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034384 |
high-density lipoprotein particle clearance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034382 |
chylomicron remnant clearance |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034380 |
high-density lipoprotein particle assembly |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034375 |
high-density lipoprotein particle remodeling |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034372 |
very-low-density lipoprotein particle remodeling |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0034372 |
very-low-density lipoprotein particle remodeling |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034363 |
intermediate-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034362 |
low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0033700 |
phospholipid efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0033344 |
cholesterol efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0033344 |
cholesterol efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0032805 |
positive regulation of low-density lipoprotein particle receptor catabolic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0032489 |
regulation of Cdc42 protein signal transduction |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0030425 |
dendrite |
ECO:0000303 |
author statement without traceable support used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0030195 |
negative regulation of blood coagulation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0019934 |
cGMP-mediated signaling |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0016209 |
antioxidant activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010875 |
positive regulation of cholesterol efflux |
ECO:0000316 |
genetic interaction evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010875 |
positive regulation of cholesterol efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010873 |
positive regulation of cholesterol esterification |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0010544 |
negative regulation of platelet activation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0008203 |
cholesterol metabolic process |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0008203 |
cholesterol metabolic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0008201 |
heparin binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0007263 |
nitric oxide mediated signal transduction |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0007186 |
G protein-coupled receptor signaling pathway |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006898 |
receptor-mediated endocytosis |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006641 |
triglyceride metabolic process |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006641 |
triglyceride metabolic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0005737 |
cytoplasm |
ECO:0000303 |
author statement without traceable support used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0005615 |
extracellular space |
ECO:0007005 |
high throughput direct assay evidence used in manual assertion |
C |
part_of:(UBERON:0001496) |
Seeded From UniProt |
complete | ||
enables |
GO:0005543 |
phospholipid binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0005319 |
lipid transporter activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0001937 |
negative regulation of endothelial cell proliferation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0008289 |
lipid binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000314 |
direct assay evidence used in manual assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0000302 |
response to reactive oxygen species |
ECO:0000303 |
author statement without traceable support used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0098978 |
glutamatergic synapse |
ECO:0006042 |
cell fractionation evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
part_of |
GO:0098978 |
glutamatergic synapse |
ECO:0005589 |
confocal microscopy evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
part_of |
GO:0098978 |
glutamatergic synapse |
ECO:0000279 |
western blot evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
part_of |
GO:0043083 |
synaptic cleft |
ECO:0006042 |
cell fractionation evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
part_of |
GO:0043083 |
synaptic cleft |
ECO:0005589 |
confocal microscopy evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
part_of |
GO:0043083 |
synaptic cleft |
ECO:0000279 |
western blot evidence used in manual assertion |
C |
|
Seeded From UniProt |
complete | ||
involved_in |
GO:1900221 |
regulation of amyloid-beta clearance |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0070326 |
very-low-density lipoprotein particle receptor binding |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
F |
Seeded From UniProt |
complete | ||
enables |
GO:0060228 |
phosphatidylcholine-sterol O-acyltransferase activator activity |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0051000 |
positive regulation of nitric-oxide synthase activity |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0050750 |
low-density lipoprotein particle receptor binding |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0046889 |
positive regulation of lipid biosynthetic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0043691 |
reverse cholesterol transport |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0043524 |
negative regulation of neuron apoptotic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042632 |
cholesterol homeostasis |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0042627 |
chylomicron |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042159 |
lipoprotein catabolic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042157 |
lipoprotein metabolic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034380 |
high-density lipoprotein particle assembly |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034372 |
very-low-density lipoprotein particle remodeling |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
C |
Seeded From UniProt |
complete | ||
part_of |
GO:0034363 |
intermediate-density lipoprotein particle |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0033700 |
phospholipid efflux |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0033344 |
cholesterol efflux |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88049 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0032374 |
regulation of cholesterol transport |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0019433 |
triglyceride catabolic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0017127 |
cholesterol transporter activity |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88049 |
F |
Seeded From UniProt |
complete | ||
enables |
GO:0015485 |
cholesterol binding |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010873 |
positive regulation of cholesterol esterification |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006707 |
cholesterol catabolic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88057 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006695 |
cholesterol biosynthetic process |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:88049 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0005543 |
phospholipid binding |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439006 |
F |
Seeded From UniProt |
complete | ||
enables |
GO:0001540 |
amyloid-beta binding |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000439008 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0098869 |
cellular oxidant detoxification |
ECO:0000364 |
evidence based on logical inference from manual annotation used in automatic assertion |
GO:0016209 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:1905907 |
negative regulation of amyloid fibril formation |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:1900223 |
positive regulation of amyloid-beta clearance |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0098978 |
glutamatergic synapse |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0097006 |
regulation of plasma lipoprotein particle levels |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0090209 |
negative regulation of triglyceride metabolic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0072358 |
cardiovascular system development |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0071830 |
triglyceride-rich lipoprotein particle clearance |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0071813 |
lipoprotein particle binding |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0070328 |
triglyceride homeostasis |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0060228 |
phosphatidylcholine-sterol O-acyltransferase activator activity |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0055088 |
lipid homeostasis |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0051651 |
maintenance of location in cell |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0050807 |
regulation of synapse organization |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0050728 |
negative regulation of inflammatory response |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0048844 |
artery morphogenesis |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0045088 |
regulation of innate immune response |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0043395 |
heparan sulfate proteoglycan binding |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042981 |
regulation of apoptotic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042632 |
cholesterol homeostasis |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042311 |
vasodilation |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042159 |
lipoprotein catabolic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042158 |
lipoprotein biosynthetic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042157 |
lipoprotein metabolic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034374 |
low-density lipoprotein particle remodeling |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034372 |
very-low-density lipoprotein particle remodeling |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0034362 |
low-density lipoprotein particle |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0033344 |
cholesterol efflux |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0017127 |
cholesterol transporter activity |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010976 |
positive regulation of neuron projection development |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010877 |
lipid transport involved in lipid storage |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010873 |
positive regulation of cholesterol esterification |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010629 |
negative regulation of gene expression |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0010468 |
regulation of gene expression |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0008203 |
cholesterol metabolic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006979 |
response to oxidative stress |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006874 |
cellular calcium ion homeostasis |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006707 |
cholesterol catabolic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006629 |
lipid metabolic process |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0005615 |
extracellular space |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0002021 |
response to dietary excess |
ECO:0000265 |
sequence orthology evidence used in automatic assertion |
UniProtKB:P08226 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0005576 |
extracellular region |
ECO:0000256 |
match to sequence model evidence used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006869 |
lipid transport |
ECO:0000256 |
match to sequence model evidence used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0008289 |
lipid binding |
ECO:0000256 |
match to sequence model evidence used in automatic assertion |
F |
Seeded From UniProt |
complete | |||
involved_in |
GO:0042157 |
lipoprotein metabolic process |
ECO:0000256 |
match to sequence model evidence used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1903001 |
negative regulation of lipid transport across blood-brain barrier |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
has_input:(CHEBI:28125) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1902999 |
negative regulation of phospholipid efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1902998 |
positive regulation of neurofibrillary tangle assembly |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1902951 |
negative regulation of dendritic spine maintenance |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1902947 |
regulation of tau-protein kinase activity |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000540) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1902004 |
positive regulation of amyloid-beta formation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1902004 |
positive regulation of amyloid-beta formation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000540) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1901627 |
negative regulation of postsynaptic membrane organization |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0034205) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1901216 |
positive regulation of neuron death |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0034205) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1901214 |
regulation of neuron death |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0090370 |
negative regulation of cholesterol efflux |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0061000 |
negative regulation of dendritic spine development |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0048666) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0051055 |
negative regulation of lipid biosynthetic process |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
occurs_in:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1902430 |
negative regulation of amyloid-beta formation |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:1901631 |
positive regulation of presynaptic membrane organization |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
during:(GO:0034205) |
Seeded From UniProt |
complete | ||
involved_in |
GO:1905908 |
positive regulation of amyloid fibril formation |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0034365 |
discoidal high-density lipoprotein particle |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
C |
produced_by:(CL:0000127) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006898 |
receptor-mediated endocytosis |
PMID:22138302[19] |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
P |
has_input:(GO:1990777) |
Seeded From UniProt |
complete |
enables |
GO:0005198 |
structural molecule activity |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
F |
has_input:(GO:1990777) |
Seeded From UniProt |
complete | ||
involved_in |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0048168 |
regulation of neuronal synaptic plasticity |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0046907 |
intracellular transport |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0030516 |
regulation of axon extension |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0007271 |
synaptic transmission, cholinergic |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0007010 |
cytoskeleton organization |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0005737 |
cytoplasm |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0071682 |
endocytic vesicle lumen |
Reactome:R-HSA-2507854 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0044267 |
cellular protein metabolic process |
Reactome:R-HSA-392499 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0043687 |
post-translational protein modification |
Reactome:R-HSA-597592 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034382 |
chylomicron remnant clearance |
Reactome:R-HSA-8964026 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034378 |
chylomicron assembly |
Reactome:R-HSA-8963888 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034375 |
high-density lipoprotein particle remodeling |
Reactome:R-HSA-8964058 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0034371 |
chylomicron remodeling |
Reactome:R-HSA-8963901 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0030669 |
clathrin-coated endocytic vesicle membrane |
Reactome:R-HSA-174706 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006357 |
regulation of transcription by RNA polymerase II |
Reactome:R-HSA-8864260 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0005886 |
plasma membrane |
Reactome:R-HSA-174706 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
C |
Seeded From UniProt |
complete | |
part_of |
GO:0005788 |
endoplasmic reticulum lumen |
Reactome:R-HSA-8952289 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
C |
Seeded From UniProt |
complete | ||
part_of |
GO:0005769 |
early endosome |
Reactome:R-HSA-2429643 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
C |
Seeded From UniProt |
complete | |
part_of |
GO:0005576 |
extracellular region |
Reactome:R-HSA-8869590 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
C |
Seeded From UniProt |
complete | |
involved_in |
GO:0001523 |
retinoid metabolic process |
Reactome:R-HSA-975634 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0008203 |
cholesterol metabolic process |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0042627 |
chylomicron |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0008202 |
steroid metabolic process |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
enables |
GO:0008201 |
heparin binding |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
F |
Seeded From UniProt |
complete | |||
enables |
GO:0008289 |
lipid binding |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
F |
Seeded From UniProt |
complete | |||
part_of |
GO:0005576 |
extracellular region |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0034361 |
very-low-density lipoprotein particle |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006629 |
lipid metabolic process |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0034364 |
high-density lipoprotein particle |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006869 |
lipid transport |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0005615 |
extracellular space |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.0 1.1 1.2 Krimbou, L et al. (2004) Molecular interactions between apoE and ABCA1: impact on apoE lipidation. J. Lipid Res. 45 839-48 PubMed GONUTS page
- ↑ 2.0 2.1 Verghese, PB et al. (2013) ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc. Natl. Acad. Sci. U.S.A. 110 E1807-16 PubMed GONUTS page
- ↑ 3.0 3.1 Burgess, JW et al. (1998) The HepG2 extracellular matrix contains separate heparinase- and lipid-releasable pools of ApoE. Implications for hepatic lipoprotein metabolism. J. Biol. Chem. 273 5645-54 PubMed GONUTS page
- ↑ Kowal, RC et al. (1989) Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 86 5810-4 PubMed GONUTS page
- ↑ 5.0 5.1 Gonzales, JC et al. (2013) Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. J. Clin. Invest. 123 2742-51 PubMed GONUTS page
- ↑ Fagan, AM et al. (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271 30121-5 PubMed GONUTS page
- ↑ 7.0 7.1 Westerlund, JA & Weisgraber, KH (1993) Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268 15745-50 PubMed GONUTS page
- ↑ Yan, X et al. (2016) FRMD4A-cytohesin signaling modulates the cellular release of tau. J. Cell. Sci. 129 2003-15 PubMed GONUTS page
- ↑ 9.0 9.1 9.2 9.3 Weisgraber, KH (1990) Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31 1503-11 PubMed GONUTS page
- ↑ 10.0 10.1 Mann, WA et al. (1995) Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu). J. Clin. Invest. 96 1100-7 PubMed GONUTS page
- ↑ Dong, LM et al. (1992) Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3----Lys) and its binding to low density lipoprotein receptors. Biochem. Biophys. Res. Commun. 187 1180-6 PubMed GONUTS page
- ↑ 12.0 12.1 12.2 Huang, YA et al. (2017) ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion. Cell 168 427-441.e21 PubMed GONUTS page
- ↑ 13.0 13.1 Dong, LM et al. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269 22358-65 PubMed GONUTS page
- ↑ Pencheva, N et al. (2012) Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151 1068-82 PubMed GONUTS page
- ↑ Yeh, FL et al. (2016) TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron 91 328-40 PubMed GONUTS page
- ↑ 16.0 16.1 16.2 16.3 Sehayek, E & Eisenberg, S (1991) Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266 18259-67 PubMed GONUTS page
- ↑ Arnon, R et al. (1991) Effects of exogenous apo E-3 and of cholesterol-enriched meals on the cellular metabolism of human chylomicrons and their remnants. Biochim. Biophys. Acta 1085 336-42 PubMed GONUTS page
- ↑ 18.0 18.1 18.2 18.3 Garai, K et al. (2014) The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation. Biochemistry 53 6323-31 PubMed GONUTS page
- ↑ 19.0 19.1 19.2 19.3 19.4 19.5 19.6 19.7 19.8 LaDu, MJ et al. (2012) Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim. Biophys. Acta 1821 295-302 PubMed GONUTS page
- ↑ Hopkins, PC et al. (2011) The impact of a novel apolipoprotein E and amyloid-β protein precursor-interacting protein on the production of amyloid-β. J. Alzheimers Dis. 26 239-53 PubMed GONUTS page
- ↑ Yun, SH et al. (2005) Blockade of nicotinic acetylcholine receptors suppresses hippocampal long-term potentiation in wild-type but not ApoE4 targeted replacement mice. J. Neurosci. Res. 82 771-7 PubMed GONUTS page
- ↑ 22.0 22.1 22.2 22.3 22.4 22.5 22.6 22.7 Johnson, LA et al. (2014) Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol. Dis. 64 150-62 PubMed GONUTS page
- ↑ Yang, DS et al. (1997) Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68 721-5 PubMed GONUTS page
- ↑ 24.0 24.1 Ji, ZS et al. (1994) Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269 2764-72 PubMed GONUTS page
- ↑ Barallobre-Barreiro, J et al. (2016) Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins. Cardiovasc. Res. 110 419-30 PubMed GONUTS page
- ↑ Bachmeier, C et al. (2014) Apolipoprotein E isoform-specific effects on lipoprotein receptor processing. Neuromolecular Med. 16 686-96 PubMed GONUTS page
- ↑ 27.0 27.1 27.2 27.3 27.4 27.5 LaDu, MJ et al. (1997) Association of human, rat, and rabbit apolipoprotein E with beta-amyloid. J. Neurosci. Res. 49 9-18 PubMed GONUTS page
- ↑ 28.0 28.1 Kim, J et al. (2009) Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance. Neuron 64 632-44 PubMed GONUTS page
- ↑ Barallobre-Barreiro, J et al. (2016) Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. Circulation 134 817-32 PubMed GONUTS page
- ↑ 30.0 30.1 30.2 Bellosta, S et al. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270 27063-71 PubMed GONUTS page
- ↑ Hussain, A et al. (2013) Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture. J. Biomed. Sci. 20 49 PubMed GONUTS page
- ↑ 32.0 32.1 32.2 LaDu, MJ et al. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269 23403-6 PubMed GONUTS page
- ↑ 33.0 33.1 33.2 33.3 33.4 33.5 Caruso, A et al. (2006) Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J. Neurochem. 98 364-71 PubMed GONUTS page
- ↑ 34.0 34.1 34.2 Ji, ZS et al. (1993) Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268 10160-7 PubMed GONUTS page
- ↑ 35.0 35.1 35.2 35.3 Lee, JY et al. (2014) Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins. J. Virol. 88 12422-37 PubMed GONUTS page
- ↑ Principe, S et al. (2013) In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics 13 1667-71 PubMed GONUTS page
- ↑ Soteriou, D et al. (2013) Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance. J. Biol. Chem. 288 18716-31 PubMed GONUTS page
- ↑ Chiasserini, D et al. (2014) Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics 106 191-204 PubMed GONUTS page
- ↑ Ghosh, D et al. (2010) Defining the membrane proteome of NK cells. J Mass Spectrom 45 1-25 PubMed GONUTS page
- ↑ 40.0 40.1 40.2 40.3 Vandal, M et al. (2014) Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2. J. Neurochem. 129 516-26 PubMed GONUTS page
- ↑ 41.0 41.1 41.2 41.3 41.4 41.5 Gong, JS et al. (2002) Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J. Biol. Chem. 277 29919-26 PubMed GONUTS page
- ↑ 42.0 42.1 42.2 42.3 42.4 42.5 Nwabuisi-Heath, E et al. (2014) ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro. ASN Neuro 6 e00134 PubMed GONUTS page
- ↑ 43.0 43.1 43.2 43.3 43.4 Zhao, W et al. (2014) Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model. Hum. Mol. Genet. 23 1365-75 PubMed GONUTS page
- ↑ 44.0 44.1 44.2 44.3 44.4 44.5 44.6 44.7 Hudry, E et al. (2013) Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med 5 212ra161 PubMed GONUTS page
- ↑ 45.0 45.1 Mulder, SD et al. (2014) Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro. Glia 62 493-503 PubMed GONUTS page
- ↑ Bastos-Amador, P et al. (2012) Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J Proteomics 75 3574-84 PubMed GONUTS page
- ↑ Gonzales, PA et al. (2009) Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 20 363-79 PubMed GONUTS page
- ↑ Buschow, SI et al. () MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol. Cell Biol. 88 851-6 PubMed GONUTS page
- ↑ de Mateo, S et al. (2011) Proteomic characterization of the human sperm nucleus. Proteomics 11 2714-26 PubMed GONUTS page
- ↑ Palmer, DJ et al. (2006) Human colostrum: identification of minor proteins in the aqueous phase by proteomics. Proteomics 6 2208-16 PubMed GONUTS page
- ↑ Li, X et al. (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain. Biochemistry 42 10406-17 PubMed GONUTS page
- ↑ Takahashi, S et al. (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. U.S.A. 89 9252-6 PubMed GONUTS page
- ↑ 53.0 53.1 53.2 Zhao, Y et al. (2005) Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins. Biochemistry 44 1013-25 PubMed GONUTS page
- ↑ 54.0 54.1 Hoe, HS & Rebeck, GW (2005) Regulation of ApoE receptor proteolysis by ligand binding. Brain Res. Mol. Brain Res. 137 31-9 PubMed GONUTS page
- ↑ 55.0 55.1 55.2 55.3 55.4 55.5 Riddell, DR et al. (1997) Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. J. Biol. Chem. 272 89-95 PubMed GONUTS page
- ↑ Nilsson, SK et al. (2007) Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 46 3896-904 PubMed GONUTS page
- ↑ 57.0 57.1 Innerarity, TL et al. (1978) Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. J. Biol. Chem. 253 6289-95 PubMed GONUTS page
- ↑ Huang, DY et al. (1995) ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neurosci. Lett. 192 209-12 PubMed GONUTS page
- ↑ 59.0 59.1 59.2 59.3 59.4 Ishigami, M et al. (1998) Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J. Biol. Chem. 273 20156-61 PubMed GONUTS page
- ↑ Huang, Y et al. (1994) A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. U.S.A. 91 1834-8 PubMed GONUTS page
- ↑ 61.0 61.1 61.2 Han, SH et al. (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53 535-44 PubMed GONUTS page
- ↑ 62.0 62.1 62.2 62.3 Connelly, PW et al. (1993) Identification of disulfide-linked apolipoprotein species in human lipoproteins. J. Lipid Res. 34 1717-27 PubMed GONUTS page
- ↑ 63.0 63.1 63.2 Yokoyama, S et al. (1985) Behavior of human apolipoprotein E in aqueous solutions and at interfaces. J. Biol. Chem. 260 16375-82 PubMed GONUTS page
- ↑ 64.0 64.1 64.2 64.3 Sullivan, PM et al. (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102 130-5 PubMed GONUTS page
- ↑ Jackson, KG et al. (2006) Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids. Nutr Metab Cardiovasc Dis 16 405-17 PubMed GONUTS page
- ↑ Breslow, JL et al. (1982) Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J. Lipid Res. 23 1224-35 PubMed GONUTS page
- ↑ 67.0 67.1 Vedhachalam, C et al. (2007) The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry 46 2583-93 PubMed GONUTS page
- ↑ 68.0 68.1 68.2 Hopkins, PC et al. (2002) Evidence for differential effects of apoE3 and apoE4 on HDL metabolism. J. Lipid Res. 43 1881-9 PubMed GONUTS page
- ↑ Weisgraber, KH & Mahley, RW (1978) Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J. Biol. Chem. 253 6281-8 PubMed GONUTS page
- ↑ Meyer, BJ et al. (2007) Fractionation of cholesteryl ester rich intermediate density lipoprotein subpopulations by chondroitin sulphate. Atherosclerosis 195 e28-34 PubMed GONUTS page
- ↑ Mancone, C et al. (2007) Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics 7 143-54 PubMed GONUTS page
- ↑ 72.0 72.1 Remaley, AT et al. (2001) Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280 818-23 PubMed GONUTS page
- ↑ 73.0 73.1 73.2 Nofer, JR et al. (2006) Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J. Lipid Res. 47 794-803 PubMed GONUTS page
- ↑ 74.0 74.1 Schaefer, EJ et al. (1986) Familial apolipoprotein E deficiency. J. Clin. Invest. 78 1206-19 PubMed GONUTS page
- ↑ Fielding, PE et al. (1989) Apolipoprotein E mediates binding of normal very low density lipoprotein to heparin but is not required for high affinity receptor binding. J. Biol. Chem. 264 12462-6 PubMed GONUTS page
- ↑ Didangelos, A et al. (2010) Proteomics characterization of extracellular space components in the human aorta. Mol. Cell Proteomics 9 2048-62 PubMed GONUTS page
- ↑ Cho, HS et al. (2001) Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J. Neuropathol. Exp. Neurol. 60 342-9 PubMed GONUTS page
- ↑ Lauderback, CM et al. (2002) Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res. 924 90-7 PubMed GONUTS page
- ↑ 79.0 79.1 79.2 79.3 79.4 79.5 Koffie, RM et al. (2012) Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. Brain 135 2155-68 PubMed GONUTS page
- ↑ 80.00 80.01 80.02 80.03 80.04 80.05 80.06 80.07 80.08 80.09 80.10 80.11 80.12 80.13 80.14 80.15 80.16 80.17 80.18 80.19 80.20 80.21 80.22 80.23 80.24 80.25 80.26 Gaudet, P et al. (2011) Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief. Bioinformatics 12 449-62 PubMed GONUTS page
- ↑ Hammad, SM et al. (1997) Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J. Biol. Chem. 272 18644-9 PubMed GONUTS page
- ↑ Basak, JM et al. (2012) Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes. J. Biol. Chem. 287 13959-71 PubMed GONUTS page
- ↑ Berwick, DC & Harvey, K (2012) The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem. Soc. Trans. 40 1123-8 PubMed GONUTS page
- ↑ 84.0 84.1 84.2 84.3 84.4 84.5 Beffert, U et al. (1998) The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res. Brain Res. Rev. 27 119-42 PubMed GONUTS page
a
c
- GO:0072358 ! cardiovascular system development
- Catarrhini
- GO:0098869 ! cellular oxidant detoxification
- GO:0044267 ! cellular protein metabolic process
- GO:0019934 ! cGMP-mediated signaling
- GO:0006707 ! cholesterol catabolic process
- GO:0006695 ! cholesterol biosynthetic process
- GO:0042632 ! cholesterol homeostasis
- GO:0008203 ! cholesterol metabolic process
- GO:0015485 ! cholesterol binding
- GO:0017127 ! cholesterol transporter activity
- GO:0033344 ! cholesterol efflux
- Chordata
- GO:0042627 ! chylomicron
- GO:0034371 ! chylomicron remodeling
- GO:0034382 ! chylomicron remnant clearance
- GO:0034360 ! chylomicron remnant
- GO:0034378 ! chylomicron assembly
- GO:0030669 ! clathrin-coated endocytic vesicle membrane
- Craniata
- GO:0005737 ! cytoplasm
- GO:0007010 ! cytoskeleton organization
d
e
- GO:0005769 ! early endosome
- GO:0071682 ! endocytic vesicle lumen
- GO:0005783 ! endoplasmic reticulum
- GO:0005788 ! endoplasmic reticulum lumen
- Euarchontoglires
- Eukaryota
- Euteleostomi
- Eutheria
- GO:0031240 ! external side of cell outer membrane
- GO:0005576 ! extracellular region
- GO:1903561 ! extracellular vesicle
- GO:0070062 ! extracellular exosome
- GO:0005615 ! extracellular space
- GO:0031012 ! extracellular matrix
g
h
- Haplorrhini
- GO:0043395 ! heparan sulfate proteoglycan binding
- GO:0008201 ! heparin binding
- GO:0034384 ! high-density lipoprotein particle clearance
- GO:0034375 ! high-density lipoprotein particle remodeling
- GO:0034380 ! high-density lipoprotein particle assembly
- GO:0034364 ! high-density lipoprotein particle
- Hominidae
- Homo
- Homo sapiens
i
l
- GO:0008289 ! lipid binding
- GO:0055088 ! lipid homeostasis
- GO:0006629 ! lipid metabolic process
- GO:0010877 ! lipid transport involved in lipid storage
- GO:0006869 ! lipid transport
- GO:0005319 ! lipid transporter activity
- GO:1990777 ! lipoprotein particle
- GO:0042158 ! lipoprotein biosynthetic process
- GO:0042159 ! lipoprotein catabolic process
- GO:0071813 ! lipoprotein particle binding
- GO:0042157 ! lipoprotein metabolic process
- GO:0035641 ! locomotory exploration behavior
- GO:0015909 ! long-chain fatty acid transport
- GO:0007616 ! long-term memory
- GO:0050750 ! low-density lipoprotein particle receptor binding
- GO:0034362 ! low-density lipoprotein particle
- GO:0034374 ! low-density lipoprotein particle remodeling
m
n
- GO:1903001 ! negative regulation of lipid transport across blood-brain barrier
- GO:1902999 ! negative regulation of phospholipid efflux
- GO:1901627 ! negative regulation of postsynaptic membrane organization
- GO:1902951 ! negative regulation of dendritic spine maintenance
- GO:0010544 ! negative regulation of platelet activation
- GO:0043524 ! negative regulation of neuron apoptotic process
- GO:0001937 ! negative regulation of endothelial cell proliferation
- GO:0030195 ! negative regulation of blood coagulation
- GO:1900272 ! negative regulation of long-term synaptic potentiation
- GO:0043407 ! negative regulation of MAP kinase activity
- GO:0010977 ! negative regulation of neuron projection development
- GO:0045541 ! negative regulation of cholesterol biosynthetic process
- GO:0010629 ! negative regulation of gene expression
- GO:1902430 ! negative regulation of amyloid-beta formation
- GO:1901630 ! negative regulation of presynaptic membrane organization
- GO:0032269 ! negative regulation of cellular protein metabolic process
- GO:0050709 ! negative regulation of protein secretion
- GO:0090090 ! negative regulation of canonical Wnt signaling pathway
- GO:0050728 ! negative regulation of inflammatory response
- GO:0010596 ! negative regulation of endothelial cell migration
- GO:0051055 ! negative regulation of lipid biosynthetic process
- GO:1905907 ! negative regulation of amyloid fibril formation
- GO:0090370 ! negative regulation of cholesterol efflux
- GO:0061000 ! negative regulation of dendritic spine development
- GO:0090209 ! negative regulation of triglyceride metabolic process
- GO:0043537 ! negative regulation of blood vessel endothelial cell migration
- GO:0043025 ! neuronal cell body
- GO:0048666 ! neuron development
- GO:0031175 ! neuron projection development
- GO:0007263 ! nitric oxide mediated signal transduction
- GO:0097114 ! NMDA glutamate receptor clustering
- GO:0005634 ! nucleus
o
- GO:0062023 ! obsolete collagen-containing extracellular matrix
- GO:1901215 ! obsolete negative regulation of neuron death
- GO:0010873 ! obsolete positive regulation of cholesterol esterification
- GO:1905860 ! obsolete positive regulation of heparan sulfate proteoglycan binding
- GO:1901216 ! obsolete positive regulation of neuron death
- GO:1905855 ! obsolete positive regulation of heparan sulfate binding
- GO:1901214 ! obsolete regulation of neuron death
p
- GO:0060228 ! phosphatidylcholine-sterol O-acyltransferase activator activity
- GO:0033700 ! phospholipid efflux
- GO:0005543 ! phospholipid binding
- GO:0005886 ! plasma membrane
- GO:1905908 ! positive regulation of amyloid fibril formation
- GO:0060999 ! positive regulation of dendritic spine development
- GO:0010976 ! positive regulation of neuron projection development
- GO:0032805 ! positive regulation of low-density lipoprotein particle receptor catabolic process
- GO:0051000 ! positive regulation of nitric-oxide synthase activity
- GO:1902004 ! positive regulation of amyloid-beta formation
- GO:1902998 ! positive regulation of neurofibrillary tangle assembly
- GO:0045893 ! positive regulation of DNA-templated transcription
- GO:0010875 ! positive regulation of cholesterol efflux
- GO:0046889 ! positive regulation of lipid biosynthetic process
- GO:0070374 ! positive regulation of ERK1 and ERK2 cascade
- GO:1901631 ! positive regulation of presynaptic membrane organization
- GO:0051044 ! positive regulation of membrane protein ectodomain proteolysis
- GO:0044794 ! positive regulation by host of viral process
- GO:1902952 ! positive regulation of dendritic spine maintenance
- GO:0045807 ! positive regulation of endocytosis
- GO:1900223 ! positive regulation of amyloid-beta clearance
- GO:1902995 ! positive regulation of phospholipid efflux
- GO:1903002 ! positive regulation of lipid transport across blood-brain barrier
- GO:1901628 ! positive regulation of postsynaptic membrane organization
- GO:0043687 ! post-translational protein modification
- Primates
- GO:0044877 ! protein-containing complex binding
- GO:0046983 ! protein dimerization activity
- GO:0042803 ! protein homodimerization activity
- GO:0017038 ! protein import
- GO:0006497 ! protein lipidation
r
- GO:0006898 ! receptor-mediated endocytosis
- GO:0006357 ! regulation of transcription by RNA polymerase II
- GO:0061136 ! regulation of proteasomal protein catabolic process
- GO:0032462 ! regulation of protein homooligomerization
- GO:0030516 ! regulation of axon extension
- GO:0048168 ! regulation of neuronal synaptic plasticity
- GO:1900221 ! regulation of amyloid-beta clearance
- GO:2000822 ! regulation of behavioral fear response
- GO:0051246 ! regulation of protein metabolic process
- GO:0097006 ! regulation of plasma lipoprotein particle levels
- GO:0032374 ! regulation of cholesterol transport
- GO:1905890 ! regulation of cellular response to very-low-density lipoprotein particle stimulus
- GO:0050807 ! regulation of synapse organization
- GO:1905906 ! regulation of amyloid fibril formation
- GO:0032489 ! regulation of Cdc42 protein signal transduction
- GO:1902947 ! regulation of tau-protein kinase activity
- GO:0090181 ! regulation of cholesterol metabolic process
- GO:0045088 ! regulation of innate immune response
- GO:0042981 ! regulation of apoptotic process
- GO:0010468 ! regulation of gene expression
- GO:0006979 ! response to oxidative stress
- GO:0061771 ! response to caloric restriction
- GO:0002021 ! response to dietary excess
- GO:0000302 ! response to reactive oxygen species
- GO:0001523 ! retinoid metabolic process
- GO:0043691 ! reverse cholesterol transport
s
t
v
- GO:0042311 ! vasodilation
- Vertebrata
- GO:0034447 ! very-low-density lipoprotein particle clearance
- GO:0034372 ! very-low-density lipoprotein particle remodeling
- GO:0070326 ! very-low-density lipoprotein particle receptor binding
- GO:0034361 ! very-low-density lipoprotein particle
- GO:0019068 ! virion assembly